RRD-251 is a small molecule disruptor of the Rb–Raf-1 interaction that significantly inhibits angiogenesis and tumor growth both in vitro and in vivo in a pRb-dependent manner [12], [14]. This evidence concerns the gene RB1 and neoplasm.